Literature DB >> 15623492

Mutational screening of the CD40 ligand (CD40L) gene in patients with X linked hyper-IgM syndrome (XHIM) and determination of carrier status in female relatives.

M L Prasad1, M Velickovic, S A Weston, E M Benson.   

Abstract

AIMS: To analyse the gene encoding the CD40 ligand (CD40L) in 11 Australian patients from 10 unrelated families with the X linked hyper-IgM (XHIM) phenotype.
METHODS: The CD40L gene was screened for mutations using direct sequencing of exon specific polymerase chain reaction (PCR) products.
RESULTS: Ten mutations were identified. Seven of these mutations have been described previously, whereas three new nonsense mutations were identified, namely: E108X (c.322G>T), G167X (c.499G>T), and C218X (c.654C>A). Ten of 15 female family members revealed both a mutated allele and a normal allele, indicating that they were XHIM carriers.
CONCLUSION: The 10 mutations (including the three new ones) identified in this study reflect the heterogeneity of the CD40L gene, and indicate the need for accurate and reliable molecular testing of those patients suspected of XHIM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15623492      PMCID: PMC1770534          DOI: 10.1136/jcp.2004.019711

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion.

Authors:  J T den Dunnen; S E Antonarakis
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

2.  CD154 variants associated with hyper-IgM syndrome can form oligomers and trigger CD40-mediated signals.

Authors:  E Garber; L Su; B Ehrenfels; M Karpusas; Y M Hsu
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

3.  Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies).

Authors:  M E Conley; L D Notarangelo; A Etzioni
Journal:  Clin Immunol       Date:  1999-12       Impact factor: 3.969

Review 4.  Immunogenetics: changing the face of immunodeficiency.

Authors:  A M Jones; H B Gaspar
Journal:  J Clin Pathol       Date:  2000-01       Impact factor: 3.411

5.  Immunological and genetic analysis of 65 patients with a clinical suspicion of X linked hyper-IgM.

Authors:  K C Gilmour; D Walshe; S Heath; G Monaghan; S Loughlin; T Lester; G Norbury; C M Cale
Journal:  Mol Pathol       Date:  2003-10

6.  Structural organization of the gene for CD40 ligand: molecular analysis for diagnosis of X-linked hyper-IgM syndrome.

Authors:  M Shimadzu; H Nunoi; H Terasaki; R Ninomiya; M Iwata; S Kanegasaka; I Matsuda
Journal:  Biochim Biophys Acta       Date:  1995-01-02

7.  A single strand conformation polymorphism study of CD40 ligand. Efficient mutation analysis and carrier detection for X-linked hyper IgM syndrome.

Authors:  Q Lin; J Rohrer; R C Allen; M Larché; J M Greene; A O Shigeoka; R A Gatti; D C Derauf; J W Belmont; M E Conley
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

8.  Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome.

Authors:  K Seyama; S Nonoyama; I Gangsaas; D Hollenbaugh; H F Pabst; A Aruffo; H D Ochs
Journal:  Blood       Date:  1998-10-01       Impact factor: 22.113

Review 9.  X-linked immunodeficiency with hyper-IgM (XHIM).

Authors:  L D Notarangelo; A R Hayward
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

10.  Characterization of nine novel mutations in the CD40 ligand gene in patients with X-linked hyper IgM syndrome of various ancestry.

Authors:  P Macchi; A Villa; D Strina; M G Sacco; F Morali; D Brugnoni; S Giliani; E Mantuano; A Fasth; B Andersson
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

View more
  4 in total

Review 1.  Pitfalls of "hyper"-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature.

Authors:  A Heinold; B Hanebeck; V Daniel; J Heyder; T H Tran; B Döhler; J Greil; F-M Müller
Journal:  Infection       Date:  2010-10-28       Impact factor: 3.553

2.  First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes.

Authors:  Otavio Cabral-Marques; Stefanie Klaver; Lena F Schimke; Évelyn H Ascendino; Taj Ali Khan; Paulo Vítor Soeiro Pereira; Angela Falcai; Alexander Vargas-Hernández; Leopoldo Santos-Argumedo; Liliana Bezrodnik; Ileana Moreira; Gisela Seminario; Daniela Di Giovanni; Andrea Gómez Raccio; Oscar Porras; Cristina Worm Weber; Janaíra Fernandes Ferreira; Fabiola Scancetti Tavares; Elisa de Carvalho; Claudia França Cavalcante Valente; Gisele Kuntze; Miguel Galicchio; Alejandra King; Nelson Augusto Rosário-Filho; Milena Baptistella Grota; Maria Marluce dos Santos Vilela; Regina Sumiko Watanabe Di Gesu; Simone Lima; Leiva de Souza Moura; Eduardo Talesnik; Eli Mansour; Pérsio Roxo-Junior; Juan Carlos Aldave; Ekaterine Goudouris; Fernanda Pinto-Mariz; Laura Berrón-Ruiz; Tamara Staines-Boone; Wilmer O Córdova Calderón; María del Carmen Zarate-Hernández; Anete S Grumach; Ricardo Sorensen; Anne Durandy; Troy R Torgerson; Beatriz Tavares Costa Carvalho; Francisco Espinosa-Rosales; Hans D Ochs; Antonio Condino-Neto
Journal:  J Clin Immunol       Date:  2014-01-09       Impact factor: 8.317

3.  A novel CD40LG deletion causes the hyper-IgM syndrome with normal CD40L expression in a 6-month-old child.

Authors:  Gabriela López-Herrera; José Luis Maravillas-Montero; Alexander Vargas-Hernández; Laura Berrón-Ruíz; Emmanuel Ramírez-Sánchez; Marco Antonio Yamazaki-Nakashimada; Francisco Javier Espinosa-Rosales; Leopoldo Santos-Argumedo
Journal:  Immunol Res       Date:  2015-05       Impact factor: 2.829

4.  CD40LG mutations in Vietnamese patients with X-linked hyper-IgM syndrome; catastrophic anti-phospholipid syndrome as a new complication.

Authors:  Anh Nguyen Lien Phan; Thuy Thi Thanh Pham; Xinh Thi Phan; Nghia Huynh; Tuan Minh Nguyen; Cuc Tran Thu Cao; Duong Thuy Nguyen; Khanh Thi Xuan Luong; Tam Thi Minh Nguyen; Anh Ngoc Kim Tran; Linh Thi Truc Pham; Vy Vuong Thao Nguyen; Sigrid Swagemakers; Chi-Bao Bui; Petrus Martinus Van Hagen
Journal:  Mol Genet Genomic Med       Date:  2021-06-10       Impact factor: 2.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.